Commentary · 23 Jun 2016
Review articlePublished 2013
Do Cancer Stem Cells have an Immunomodulatory Role Different from the Bulk of Tumor Cells?
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Cancer is one of the leading causes of death worldwide. In normal settings, the immune system is responsible for clearing cancer cells from our body. However, many patients develop immune tolerance to tumor cells through upregulation of immune regulatory molecules, release of immune suppressive factors in the tumor microenvironment and/or recruitment of regulatory/suppressive cells that impede the function of other fully activated effector immune cells. In spite of significant progress that have been achieved in increasing our understanding in this field, it is unknown whether all tumor cells exert similar inhibitory effect on the immune system or only specific subset(s) of tumor cells possess this feature. There is accumulating evidence that cancer is originated and sustained by a small population of cells called “Cancer Stem Cells (CSCs)”. These cells share many characteristics of the normal stem cells including the selfrenewing ability. Thus, it is possible that they also have the immune privilege properties of normal stem cells. At least this has been shown to be the case for two types of cancers: melanoma and glioma. In this report we will review the role of CSCs in the creation of immune suppressive microenvironment which finally leads to tumor escape from the immune system surveillance.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Opinion · 2 Oct 2023
Deciphering the Role of Cancer Stem Cells in Tumor Progression and Therapy Resistance
Perspective · 27 May 2023
Unveiling the Role of Cancer Stem Cells in Tumor Progression and Therapeutic Resistance
Conference abstract · 11 Jul 2018
Nanomaterial carcinogenicity: Role of cancer stem cells and tumor microenvironment
Conference abstract · 26 Oct 2015
The double faced role of mesencyhmal stem cells in tumor development and potential use in cancer therapy
More from this journal
The newest in Journal of Carcinogenesis & Mutagenesis.
Article · 10 Aug 2026
In vitro growth-inhibitory effects of DMTAP-containing cationic hybrid liposomes (DMTAP-cHL) on cholangiocarcinoma cells
Article · 27 May 2026
The Role of Chemical Carcinogens in Human Carcinogenesis
Article · 27 May 2026
Environmental Mutagens: Mechanisms of Action and Preventive Strategies
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Carcinogenesis & Mutagenesis
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Hazem Ghebeh”
- BylineArticles whose byline prints “Monther Al-Alwan”
